INDV
Indivior Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$31.11
+0.25 ▲ +0.81%
🌙 3월 13일 4:56 PM ET (한국 3/14 05:56)
$30.30
-0.81 ▼ -2.60%
| Index | RUT | P/E | 18.74 | EPS (ttm) | 1.66 | Insider Own | 3.29% | Shs Outstand | 0.13B | Perf Week | -3.59% |
| Market Cap | 3.89B | Forward P/E | 9.05 | EPS next Y | 11.09% | Insider Trans | 0.14% | Shs Float | 0.12B | Perf Month | -8.71% |
| Enterprise Value | 4.05B | PEG | 0.61 | EPS next Q | 0.65 | Inst Own | 94.95% | Short Float | 8.3% | Perf Quarter | -12.24% |
| Income | 0.21B | P/S | 3.14 | EPS this Y | 23.71% | Inst Trans | 1.07% | Short Ratio | 4.18 | Perf Half Y | 30.28% |
| Sales | 1.24B | P/B | - | EPS next 5Y | 14.94% | ROA | 16.53% | Short Interest | 10.01M | Perf YTD | -13.29% |
| Book/sh | -0.78 | P/C | 19.95 | EPS past 3/5Y | - | ROE | - | 52W High | -18.13% ($38.00) | Perf Year | 224.4% |
| Cash/sh | 1.56 | P/FCF | - | Sales past 3/5Y | 11.2% 13.88% | ROIC | 97.66% | 52W Low | 260.07% ($8.64) | Perf 3Y | 75.27% |
| Dividend Est. | - | EV/EBITDA | 10.71 | EPS Y/Y TTM | 751.75% | Gross Margin | 82.1% | Volatility(W/M) | 7.42% 4.89% | Perf 5Y | 275.95% |
| Dividend TTM | - | EV/Sales | 3.26 | Sales Y/Y TTM | 4.38% | Oper. Margin | 29.03% | ATR (14) | 1.73 | Perf 10Y | 180.27% |
| Dividend Ex-Date | - | Quick Ratio | 0.55 | EPS Q/Q | 410% | Profit Margin | 16.85% | RSI (14) | 38.35 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.71 | Sales Q/Q | 20.13% | SMA20 | -5.46% ($32.91) | Beta | 1.21 | Target Price | $46.86 |
| Payout | - | Debt/Eq | - | Earnings | 2000000 | SMA50 | -8.02% ($33.82) | Rel Volume | 5.55 | Prev Close | $30.86 |
| Employees | 838 | LT Debt/Eq | - | EPS/Sales Surpr. | 21.66% 17.14% | SMA200 | 18.27% ($26.3) | Avg Volume(3M) | 2.40M | Price | $31.11 |
| IPO | 2014/12/29 | Option/Short | Yes/Yes | Trades | 40756 | Volume | 13,297,326 | Change | 0.81% |
뉴스 로딩 중...